I agree that this site is using cookies. You can find further informations here.
X
Beylot-Barry, Marie
698  results:
Search for persons X
?
1

Real-life management of psoriasis with biological agents du..:

Tran, C. ; Mahé, E. ; Beylot-Barry, M....
Annales de Dermatologie et de Vénéréologie.  151 (2024)  2 - p. 103254 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Real-life efficacy of immunotherapy for Sézary syndrome: a ..:

Bozonnat, Alizée ; Beylot-Barry, Marie ; Dereure, Olivier...
eClinicalMedicine.  73 (2024)  - p. 102679 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Real-world study on the use of pegylated interferon alpha-2..:

Mitsunaga, Keila ; Bagot, Martine ; Ram-Wolff, Caroline...
British Journal of Dermatology.  , 2024
Link: https://doi.org/10.1093/..
 
?
4

Clinical impact of proton pump inhibitors and other co-medi..:

Ramel, Eloïse ; Prey, Sorilla ; Dutriaux, Caroline...
European Journal of Cancer.  197 (2024)  - p. 113477 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Treatment of moderate-to-severe psoriasis in adults: An exp..:

Poizeau, F. ; Leducq, S. ; Fardet, L....
Annales de Dermatologie et de Vénéréologie.  151 (2024)  3 - p. 103287 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Delving into the Metabolism of Sézary Cells: A Brief Review:

Cherfan, Carel ; Chebly, Alain ; Rezvani, Hamid Reza..
Genes.  15 (2024)  5 - p. 635 , 2024
Link: https://doi.org/10.3390/..
 
?
7

Improved survival over time with immunotherapy in locally a..:

Schneider, Sophie ; Ferte, Thomas ; Ducharme, Océane...
Journal of Cancer Research and Clinical Oncology.  150 (2024)  3 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
8

High response rate with extended dosing of cemiplimab in ad..:

Rischin, Danny ; Hughes, Brett G M ; Basset-Séguin, Nicole...
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e008325 , 2024
Link: https://doi.org/10.1136/..
 
?
9

Evolution of patients with Sézary syndrome after mogamulizu..:

Tzoumpa, Sofia ; Ingen-Housz-Oro, Saskia ; de Masson, Adèle...
British Journal of Dermatology.  191 (2024)  1 - p. 143-144 , 2024
Link: https://doi.org/10.1093/..
 
?
10

Safety of immune checkpoint inhibitor rechallenge after sev..:

Eldani, Céline ; Kostine, Marie ; Faure, Maxime...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
11

The KEYNOTE-630 Trial: A Phase 3 Study of Adjuvant Pembroli..:

Schenker, M. ; Klochikhin, M. ; Kirtbaya, D....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e81-e82 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Isotretinoin: Past, present and future. A French perspectiv:

Leducq, S. ; Poizeau, F. ; Chaby, G....
Annales de Dermatologie et de Vénéréologie.  151 (2024)  3 - p. 103244 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Promoting clinical research in community-based practice: Th..:

Poizeau, F. ; Maruani, A. ; Staumont-Sallé, D....
Annales de Dermatologie et de Vénéréologie.  151 (2024)  2 - p. 103272 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Impact of the first wave of the COVID-19 pandemic on the tr..:

Arlegui, H. ; Mahé, E. ; Richard, M.-A....
Annales de Dermatologie et de Vénéréologie.  150 (2023)  2 - p. 101-108 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Neurological toxicities of targeted therapies in melanoma: ..:

Hazard, Madeleine ; Duval, Fanny ; Dutriaux, Caroline...
Journal of Neurology.  271 (2023)  3 - p. 1473-1482 , 2023
Link: https://doi.org/10.1007/..
 
1-15